| Financial Year |
March 31 2023 |
| Monetary Funds |
1,283,489,898.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
482,456,060.60 |
| Accounts Receivable |
4,977,572,054.22 |
| Advances to Suppliers |
434,470,314.51 |
| Other Receivables |
686,418,388.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,411,578,599.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
64,960,270.68 |
| Total Current Assets |
11,189,963,629.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
260,890,141.63 |
| Investment Properties |
176,627,075.78 |
| Fixed Assetes |
1,105,025,504.36 |
| Under-construction Projects |
293,039,135.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
921,572,653.61 |
| R&D expenses |
200,211,698.19 |
| Goodwill |
374,336,612.48 |
| Long-Term Deferred and Prepaid Expenses |
29,884,043.59 |
| Deferred Income Tax Assets |
159,859,051.63 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,560,555,052.80 |
| Total Assets |
14,750,518,681.91 |
| Short-Term Loans |
1,265,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,279,875,549.85 |
| Accounts Payable |
4,642,091,348.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,332,093.96 |
| Taxes Payable |
90,692,141.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,854,209.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,573,660.17 |
| Other Current Liabilities |
237,541,387.32 |
| Sub-Total of Current Liabilities |
9,308,621,223.73 |
| Long-term Loans |
227,000,000.00 |
| Bonds Payable |
337,139,234.74 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
608,767,671.11 |
| Total Liabilities |
9,917,388,894.84 |
| Paid-In Capital(Or Share Stock) |
606,863,710.00 |
| Capital Surplus |
1,365,206,714.04 |
| Surplus Reserve |
221,066,837.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,298,191,285.47 |
| Minority Stockholder's Interest |
277,452,017.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,555,677,769.13 |
| Owner's Equity（Stockholder's Equity） |
4,833,129,787.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,750,518,681.91 |
